Tuesday, April 18, 2017

Podcast Interview with Steve Hawkins Talking about first Marijuana ETF; Horizons Medical #Marijuana Life Sciences (TSX: $HMMJ)

Podcast Interview with Steve Hawkins Talking about first Marijuana ETF; Horizons Medical #Marijuana Life Sciences (TSX: $HMMJ)


Point Roberts, WA, Delta BC  –April 18, 2017 – Investorideas.com, a global news source covering technology, releases a new Podcast featuring Steve Hawkins, President and Co-CEO of Horizons ETFs.  Steve talks about the world's first Marijuana ETF; Horizons Medical Marijuana Life Sciences (TSX: $HMMJ).


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.


Horizons Medical Marijuana Life Sciences ETF (“HMMJ”) seeks to replicate, to the extent possible, the performance of the North American Medical Marijuana Index, net of expenses. The North American Medical Marijuana Index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry



About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.
Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com


Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. http://www.investorideas.com/About/Disclaimer.asp


Contact Investorideas.com
Learn about being a guest on our podcasts
800-665-0411 or dvanzant@investorideas.com

Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news

Watch the 420 Cannabis Investor video


American Growth Fund Series Two ($AMREX) Added to The 420 Cannabis Investor Ideas Directory; #420CannabisInvestorideas.com




American Growth Fund Series Two ($AMREX) Added to The 420 Cannabis Investor Ideas Directory; #420CannabisInvestorideas.com

“This is a great time for the industry as a whole”- Timothy Taggart, CEO of American Growth

Pt. Roberts, WA; Delta, BC - April 18, 2017 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its affiliated directory www.420cannabisinvestorideas.com announce the most recent addition; The American Growth Fund Series Two (NASDAQ: AMREX).

The 420 Cannabis Investor Ideas directory will feature a maximum of 420 companies to be showcased for a year, including newsletters, research, experts, publicly traded companies, private companies and any service that offers insight or opportunity for investing in the sector.   Investorideas.com will create a free downloadable PDF of the full directory for investors to use as a reference and due diligence tool at the end of the year.

American Growth Fund Series Two (NASDAQ: AMREX), is currently the country's only Cannabis Mutual Fund.  Headquartered in Denver, this diversified fund focuses solely on the cannabis industry.  Approved by the SEC, it invests in publicly traded companies in areas that support this exploding industry like pharmaceuticals, agriculture, hydroponic, equipment, to name a few.




See more info and additional 420 listings on www.420cannabisinvestorideas.com



Timothy Taggart is the CEO of American Growth Fund Series Two (AMREX), currently the United States' only Cannabis Mutual Fund.  Headquartered in Denver, this diversified fund focuses solely on the cannabis industry.  Approved by the SEC, it invests in publicly traded companies in areas that support the industry like pharmaceuticals, agriculture, hydroponic, equipment, to name a few. He's been following recent week’s development and says this is a great time for the industry as a whole.

 “The legal cannabis industry is on the rise and does not seem to be slowing down. As the cannabis industry evolves we will see that some cannabis related stocks are not winners, but several of the examples that follow are a fairly good indication as to where the cannabis industry is headed. North American sales are projected to top $20.2 billion by 2021 and reach up to $50 billion in the next decade. I believe this to be true because we have seen some significant growth in several cannabis related stocks. Some of these stocks include (OTC: OWCP) which has seen a 248% growth YTD. OWCP has a cannabis based crème for Psoriasis.  Cara Therapeutics (NASDAQ: CARA) has seen a 103% growth YTD because they are developing a cannabis-based pharmaceutical product that relieves itching in pruritus patients.  They are also making headway in their medical trials with drugs related to chronic kidneys associated with pruritus. CARA not only has a 103% growth YTD but surged 15% in March according to the FMP globally market intelligence. Lastly, Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) is up 58% YTD. ZYNE has developed a CBD gel for people with epilepsy. This gel has proven to lower incidents of seizures in patients with epilepsy,” Taggart says.

Previous Investorideas.com interview with Timothy Taggart, CEO of American Growth Fund Series Two (AMREX), currently the only Cannabis Mutual Fund in the US

Learn more about how to submit your company: http://www.investorideas.com/420cannabisinvestorideas/

Watch The 420 Cannabis Investor Ideas Video: https://www.youtube.com/watch?v=e2zFezO580Y

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.
 
Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com, the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory www.420cannabisinvestorideas.com

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411



Monday, April 17, 2017

Groundbreaking Study On Marijuana Use Coincides With World Cannabis Day 4/20

Groundbreaking Study On Marijuana Use Coincides With World Cannabis Day 4/20
Majority of Americans Favor Legalization, Few Fear the Police

Toronto, ON - April 17, 2017 (Investorideas.com Newswire) Just in time for 4/20 or World Cannabis Day, DIG Insights, a leading global research firm, has released its Cannabis Culture Report, an extensive research initiative on marijuana use in North America encompassing public attitudes on usage, legalization and much more.
"Our goal was to create a custom research report that would serve as a benchmark for the growing Cannabis industry, legislators and other interested parties," said Rory McGee, research director, DIG Insights, Inc.


Legalization:
The majority of Americans (57%) support legalization, and support is highest among men (61%), particularly younger men (79%), and Millennials overall (68%). Among current users in states where marijuana is not currently legal, 37% say they are likely to consume more marijuana after it’s legalized.
Only 16% of Americans believe Marijuana is "very harmful", which is lower than alcohol (27%), processed sugar (23%) and saturated fat (33%). A majority (51%) believes consumption can be beneficial, while only 32% believe that regular users are less successful in life. However, 25% report having a close friend or family member whose life was negatively affected by marijuana.
Usage:
Among the findings, approximately 2 out of every 10 Americans (22%) have used recreational marijuana in the past year and an additional 24% would potentially use it if it became legal. Usage is highest among people aged 18-34 (30%) and those who are making less than $60K (27%). Nearly 11% of men in this age group report smoking marijuana daily.
Those who currently use marijuana report they do so to reduce stress and relieve anxiety (24%) or to promote relaxation and wellbeing (31%). Interestingly, while smoking remains the most common form of consumption, 54% have tried edibles, indicating a growing market opportunity for producers. Younger users are also more likely to have tried Vaping.
Activities:
When people are high they are most likely to watch television (52%), eat (45%), listen to music (41%), socialize (33%) or drink alcohol (31%). Younger people were less likely to combine marijuana with alcohol as compared to those over 35.
Purchase:
Most Americans get their marijuana by purchasing it directly (53%), while others consume what they get from others (26%), and 21% report having a friend or family member purchase it on their behalf. Those that purchase typically buy a quarter ounce or less. The average price is $10/gram. Where legal, 57% purchase at a dispensary. Most (42%), however, purchase at someone’s residence. A large majority (73%) report feeling very safe when purchasing marijuana and half say they’re never concerned about police intervention.
For more information or to order a copy of the Cannabis Culture Report for either the USA or Canada, please click here or email 420@diginsights.com.
About the Study:
Dig Insights Inc., a market research firm based in Toronto, Canada, conducted this study on marijuana usage and attitudes. Responses were collected online between April 3 and 7, 2017. The survey sampled n=1,108 Canadians and n=1,105 Americans aged 18-65 sourced from Research Now’s leading panel. Results have been weighted to reflect census proportions for age, gender and region in both countries. The margins of error are +/- 2.9% in each country.
Editorial Note: For infographics, please visit: http://www.diginsights.com/dig420. For interviews, please contact Ann Willets at prproann@gmail.com or call (908) 433-7821.
US CONTACT:
Ann Willets
prproann@gmail.com
(908) 433-7821


Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news



Watch the 420 Cannabis Investor video
 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Baker Launches 'Shop', the Cannabis Industry's First White Labeled E-Commerce Platform, Equipping Dispensaries with Advanced Tools They Can Rely on for Growth

Baker Launches 'Shop', the Cannabis Industry's First White Labeled E-Commerce Platform, Equipping Dispensaries with Advanced Tools They Can Rely on for Growth
Shop, 'the Shopify for Cannabis,' Provides Dispensaries with Secure, Branded, Conversion-Oriented E-commerce Sites for Pickup and Delivery


DENVER, COLO. - April 17, 2017 (Investorideas.com Newswire) Baker - the leading marketing automation platform for marijuana dispensaries and brands - today announced the launch of Shop, the most advanced cannabis-specific e-commerce platform in North America. Shop brings dispensaries and brands the online commerce capabilities that every other industry has come to rely upon. Shop, "the Shopify for Cannabis", provides dispensaries with a secure, branded, conversion-oriented e-commerce platform for pickup, delivery and shipping.
"As cannabis retail joins the 21st century, shoppers expect the same levels of personalization and convenience they've come to expect from all retail stores - and that starts online,"said David Champion, Co-Founder and Chief Product Officer for Baker. "There hasn't been a solution like Shopify, which allows retailers to easily create quality e-commerce sites that allow their customers to browse, confirm availability, and order ahead with confidence. This has forced many of them to settle for e-commerce solutions that aren't tailored to the intricacies of the industry, such as pricing by weight, medical ID verification, POS integration, and state ordering & tax limitations. With Shop, we're changing that. We're optimizing the whole marketplace for both dispensaries and their customers."
Features offered on the Shop platform include:
  • Product Notifications: Message your customers when their favorite products are back in stock
  • Quick Checkout: Get customers to buy faster with our 'Buy Now' button
  • Digital Loyalty: Keep your shoppers coming back with points and rewards
  • Multiple Fulfillment Options: Offer 21st century convenience with in-store pickup delivery, or shipping where state regulations allow
  • Advanced Product Filters: Make finding products easy with filters by category, weight, data and more
  • Compliant Nationwide: Stay compliant without lifting a finger, our team of experts has your back
Shop, which turns any dispensary's website into an e-commerce destination with one line of code, is already showing results. More than 100 retailers, across the country, are live on the platform and are seeing sales increase by as much as $115,000 per month.
Baker, which announced last month that it secured $1.6 million in funding (raising its total capital raised to $3.5 million), works with over 250 dispensaries across Arizona, California, Colorado, Connecticut, Hawaii, Nevada, New Mexico, Massachusetts, Oregon, Washington, and Ontario. The Baker platform leverages these retailers' brands to keep their customers happy and loyal, increasing revenue almost immediately. In addition to Shop, Baker's platform connects dispensary owners with in-store customers through data-driven check-in, loyalty, promotions and personalized messaging programs. Dispensaries that have switched to Baker's online menus have seen as much as a 30 percent sustained boost in sales volume and a full ROI in just six weeks.
For more information about Shop, visit http://trybaker.com/products/shop.
About Baker:
Baker is a Denver-based customer engagement and marketing automation platform for cannabis dispensaries and brands. With their data-driven approach to turn anonymous visitors into repeat customers, Baker's smart products include personalized messaging, loyalty, and online shopping. The industry-leading platform is described as the perfect recipe for a successful dispensary, with results to prove it: on average Baker clients see a 40% boost in average order size, and an ROI in just six weeks. Founded in 2014, the company graduated from notable startup accelerator 500 Startups, and is already powering the cannabis retail experience for more than 250 dispensaries and over 250,000 of their customers. Investors include Michael Lazerow, Base Ventures, XG Ventures, Poseidon Asset Management, Phyto Partners, The founders of Outside Lands, and others.


Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news



Watch the 420 Cannabis Investor video
 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Supplier for Hardware Solutions to Cannabis Industry; SinglePoint Inc. (OTC: SING) Added to 420 Cannabis Investor Ideas Directory




Supplier for Hardware Solutions to Cannabis Industry; SinglePoint Inc. (OTC: SING) Added to 420 Cannabis Investor Ideas Directory


April 17, 2017 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks, and its affiliated directory  www.420cannabisinvestorideas.com announce the most recent addition to the 420 Cannabis Investor Ideas of 2017; SinglePoint Inc. (OTC:SING), an acquisition based company focused in the cannabis space. Most recently SinglePoint acquired a stake in Convectium, a profitable company supplying hardware solutions to the cannabis industry.
The 420 Cannabis Investor Ideas of 2017 will feature a maximum of 420 companies to be showcased for a year. Investorideas.com will create a free downloadable PDF of the full directory for investors to use as a reference and due diligence tool.

SinglePoint’s (OTC: SING) flagship product is a best-in-class mobile commerce and communications platform that enables dispensaries to market to consumers through SMS messaging and accept electronic payments. By building a network of dispensaries leveraging its SMS marketing technology, the company is positioning itself to take advantage of a vast opportunity in the payments space when federal guidelines surrounding cannabis banking are finalized. The company is focused on providing business solutions to the enterprises rather than cultivation and consumers. In a market that is so heavily regulated by the government SinglePoint’s hands-off approach offers investors an opportunity to diversify their portfolio.

SinglePoint (OTC: SING) recently revamped their corporate website, aimed at providing investors easier access and transparency to the company’s initiatives. While this site will be corporate focused, SinglePoint will continue to offer solutions to the cannabis industry through its subsidiary SingleSeed.com.

New Frontier Data (also featured on the 420 Cannabis Investor Ideas Directory), the authority in business intelligence for the cannabis industry, forecasts the legal cannabis market to grow to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 16%.
Their Cannabis Industry Annual Report “2017 Legal Marijuana Outlook”, also found that if all the states which are currently legal continue their projected growth, they could generate $2.3 billion in state tax revenue from retail sales by 2020 and the U.S. Cannabis Market will Create 283,422 Jobs by 2020.
With all this money at stake its growth opportunity has been compared to the beginnings of the internet. But with all the opportunity comes the risk as well. The directory is meant to be one of several tools investors can use as a go-to resource to navigate the sector. 
See more info and additional 420 listings on www.420cannabisinvestorideas.com

Learn more about how to submit your company: http://www.investorideas.com/420cannabisinvestorideas/

Watch 420 Cannabis Investor Ideas Video: https://www.youtube.com/watch?v=e2zFezO580Y

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.
 
Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411